IMBiologics

Public

IMBiologics is now publicly traded

The data on this page reflects IMBiologics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series B

Jul 24, 2023

Total Funding Raised

$19.14M

Company Overview

IMBiologics is a biotechnology company that develops immunomodulatory antibody therapeutics for the treatment of autoimmune diseases and cancer.

AI Layer

Non-AI

Keywords

biotechnologyantibody therapeuticsbispecific antibodyautoimmune diseasedrug discoverybiologicsfusion proteinclinical developmentinflammatory diseasebiotech R&Ddrug licensingbiotech startuppharma pipelinepreclinical research

IMBiologics Comparables

Compare IMBiologics with similar companies based on industry and business-model similarity.

IMBiologics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Navigator Medicines	88%
Lmito Therapeutics	65%
ImmunAbs Inc.	64%

View all Comparables

IMBiologics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jul 24, 2023
Seed	Jan 19, 2021

View all Funding Rounds

IMBiologics Investors

Notable investors and investment history

IMBiologics investors
Investor	Rounds
K2 Investment Partners	Series B
Shinhan Venture Investment	Series B
Kingo Investment Partners	Series B
KB Investment	Series B, Seed
Ard Partners	Series B
Woori Financial Group	Series B
Yuanta Securities	Series B

View all Investors

IMBiologics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IMBiologics Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range6

Year Founded2020

Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?